Combination Antiretroviral Therapy (cART) for PBC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Mason, MD
University of Alberta
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alberta
Edmonton, Alberta, Canada
- St Paul'S Hospital, University of British Columbia
Vancouver, British Columbia, Canada
- Vancouver General Hospital, University of Brittish Columbia
Vancouver, British Columbia, Canada
- University of Toronto
Toronto, Ontario, Canada
- University of Montreal
Montreal, Quebec, Canada
- Royal University Hospital
Saskatoon, Saskatchewan, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Mar 2021
- Primary completion
- 1 Oct 2022
- Completion
- 1 Jan 2024
- Last update posted
- 16 Feb 2024
- Registered enrollment
- 37
- Registry id
- NCT03954327
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.